Laurence Reid, SVP and Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 5,000 shares at $30.00 ($150K) on 2013-05-28, disclosed to the SEC on 2013-05-30.
Scheduled sale ($150k) by SVP and Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |